background progressive pulmonary disease associated chronic bacterial infection inflammation major cause morbidity mortality cystic fibrosis cf patients identifying markers inflammation correlate lung injury useful monitoring disease progression response therapy hypothesized levels serum biomarkers correlate clinical course cf defined pulmonary function testing fev1 objective determine biomarkers systemic inflammation correlate lung function adults cf methods retrospective analysis NUMBER individuals NUMBER years age diagnosed cf childhood followed childrens hospital boston collected data demographics cftr genotype percent predicted forced expiratory volume NUMBER sec fev1 protein crp serum ige nd igg total white blood cell neutrophil counts percent neutrophils used univariate analyses multivariate linear regression modeling examine markers systemic inflammation varied fev1 predicted results models including crp marker crp p NUMBER igg p NUMBER significantly associated fev1 predicted crp igg model percent predicted fev1 decreased NUMBER p NUMBER twofold increase crp NUMBER p NUMBER NUMBER increase igg results unchanged adjustment number df NUMBER cftr alleles association marker fev1 predicted adjusting crp conclusion severity lung disease long surviving adult cf patients correlated crp igg levels findings relating crp igg levels lung function provide foundation subsequent longitudinal studies consideration novel disease mechanisms outcome measurements NUMBER cross sectional c reactive alpha1 antitrypsin covariate wiley liss mg dl